Sarcoidosis is an autoimmune granulomatous disease with unknown etiology that commonly affects the lungs. However cutaneous lesions can be found in one third of the patients and can serve as the initial signs or the only clinical manifestation of the disease. Cutaneous sarcoidosis is difficult to treat despite the use of various therapies.
Methods:
Here we report a case of cutaneous sarcoidosis treated with fractional CO2 laser therapy in combination with topical halometasone without oral medications.
Results:
The treatment areas improved gradually over several courses of fractional CO2 laser therapy.
Conclusions:
This case demonstrates that fractional CO2 laser therapy can be a viable treatment option for cutaneous sarcoidosis.
BologniaJL, JorizzoJL, RapiniRP. DERMATOLOGY. Beijing: Peking University Press. 2014.
2.
LuizaLA, StevenG, TanjaI, et al.Light and laser modalities in the treatment of cutaneous sarcoidosis: A systematic review. Acta Derm Venereol, 2018; 98(5):481–483.
3.
LabadieJG, IbrahimSA, WorleyB, et al.Evidence-based clinical practice guidelines for laser-assisted drug delivery. JAMA Dermatol, 2022; 158(10):1193–1201.
4.
HaedersdalM, SakamotoFH, FarinelliWA, et al.Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med, 2010; 42(2):113–122.
5.
ZhangP, YeJ. Application of exfoliative fractional laser-assisted drug delivery in dermatology. Journal of Clinical Dermatology, 2022; 51(5):309–312.
6.
WeiD, LiJ, ZhangY, et al.Affiliations expand a retrospective comparative cohort study of ultra-pulse fractional CO2 laser and glucocorticoids in the treatment of vulvar epithelial nonneoplastic lesions. Ann Transl Med, 2023; 11(6):260.
7.
DaiC, ShihS, AnsariA, et al.Biologic therapy in the treatment of cutaneous sarcoidosis: A literature review. Am J Clin Dermatol, 2019; 20(3):409–422.
